WHO ICTRP trial
Contrast enhanced ultrasound a novel technique in lymphatic imaging - A…
CTIS2024-519077-19-01 · EU Clinical Trials Information System · Not Recruiting
Key facts
| Trial ID | CTIS2024-519077-19-01 |
|---|---|
| Public title | Contrast enhanced ultrasound a novel technique in lymphatic imaging - A prospective study |
| Scientific title | Contrast enhanced ultrasound a novel technique in lymphatic imaging - A prospective study |
| Primary sponsor | Kuopio University Hospital |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): Yes Therapeutic confirmatory - (Phase III): Yes Therapeutic use - (Phase IV): No |
| Countries | Finland |
| Conditions | Lymphatic Imaging;Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01] |
| Interventions | Product Name: Sonazoid 8 mikroliter per ml pulver og væske til injeksjonsvæske, dispersjon, Product Code:PRD1970323, Pharmaceutical Form: DISPERSION FOR INJECTION, Other descriptive name: , Strength: |
| Registration date | Nov 22, 2024 |
| Target size | 100 |
| Secondary IDs | 2018-004389-33 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: